Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.

[1]  L. Lönn,et al.  Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. , 2005, The Journal of clinical endocrinology and metabolism.

[2]  D. Dunger,et al.  Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults. , 2004, The Journal of clinical endocrinology and metabolism.

[3]  D. Dunger,et al.  Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance. , 2004, European journal of endocrinology.

[4]  J. Stepan,et al.  The effects of GH replacement in adult GH‐deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance , 2004, Clinical endocrinology.

[5]  Oksana Gavrilova,et al.  Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. , 2003, Diabetes.

[6]  M. Savage,et al.  Insulin-Like Growth Factor (IGF)-I Gene Deletion , 2002, Reviews in Endocrine and Metabolic Disorders.

[7]  D. Dunger,et al.  Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study , 2002, The Lancet.

[8]  J. Svensson,et al.  Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. , 2002, The Journal of clinical endocrinology and metabolism.

[9]  F. Dominici,et al.  Growth Hormone-Induced Alterations in the Insulin-Signaling System , 2002, Experimental biology and medicine.

[10]  P. Sönksen,et al.  Growth hormone replacement therapy for adults: into the new millennium. , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[11]  H. Pijl,et al.  Altered neuroregulation of GH secretion in viscerally obese premenopausal women. , 2001, The Journal of clinical endocrinology and metabolism.

[12]  J. Frystyk,et al.  Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. , 2001, Diabetes.

[13]  D. M. Rocha,et al.  Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. , 1999, Diabetes.

[14]  H. Orskov,et al.  The pharmacokinetics of free insulin-like growth factor-I in healthy subjects. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[15]  D. Dunger,et al.  Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus. , 1998, Metabolism: clinical and experimental.

[16]  D. Dunger,et al.  Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus. , 1996, Hormone research.

[17]  D. Bauman,et al.  Effects of bovine somatotropin and insulin on whole-body and hindlimb glucose metabolism in growing steers. , 1995, Journal of animal science.

[18]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[19]  D. O'Neal,et al.  The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. , 1994, The Journal of clinical endocrinology and metabolism.

[20]  H. Kaji,et al.  Regulation of the Growth Hormone (GH) Receptor and GH-Binding Protein mRNA , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[21]  B. Bengtsson,et al.  Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. , 1993, Metabolism: clinical and experimental.

[22]  D. Dunger,et al.  The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short‐term euglycaemia , 1993, Clinical endocrinology.

[23]  U. Keller,et al.  Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man. , 1992, The Journal of clinical endocrinology and metabolism.

[24]  P. Butler,et al.  Effects of a physiological growth hormone pulse on substrate metabolism in insulin-dependent (type 1) diabetic subjects. , 1992, The Journal of clinical endocrinology and metabolism.

[25]  D. Dunger,et al.  Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with Type 1 (insulin-dependent) diabetes mellitus , 1992, Diabetologia.

[26]  U. Smith,et al.  Characterization of the insulin-antagonistic effect of growth hormone in man , 1991, Diabetologia.

[27]  R. Humbel,et al.  Insulin-like growth factors I and II. , 1990, European journal of biochemistry.

[28]  P. Sönksen,et al.  The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. , 1989, The New England journal of medicine.

[29]  R. Eckel,et al.  Insulinlike Growth Factor Action and Production in Adipocytes and Endothelial Cells From Human Adipose Tissue , 1989, Diabetes.

[30]  W. Rutter,et al.  Expression and characterization of a functional human insulin-like growth factor I receptor. , 1988, The Journal of biological chemistry.

[31]  M. Press,et al.  Growth hormone and metabolism. , 1988, Diabetes/metabolism reviews.

[32]  K. Alberti,et al.  Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. , 1988, The Journal of clinical investigation.

[33]  E. Froesch,et al.  Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. , 1987, The New England journal of medicine.

[34]  M. Davidson.  Effect of growth hormone on carbohydrate and lipid metabolism. , 1987, Endocrine reviews.

[35]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[36]  W. Tamborlane,et al.  Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. , 1984, The New England journal of medicine.

[37]  L. Mandarino,et al.  Effects of Growth Hormone on Insulin Action in Man: Mechanisms of Insulin Resistance, Impaired Suppression of Glucose Production, and Impaired Stimulation of Glucose Utilization , 1982, Diabetes.

[38]  D. Wilson,et al.  Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. , 1982, The Journal of clinical endocrinology and metabolism.

[39]  U. Adamson.  On the diabetogenic effect of growth hormone in man: effects of growth hormone on glucagon and insulin secretion , 1981, European journal of clinical investigation.

[40]  J. Campbell,et al.  Metasomatotrophic diabetes and its induction: Basal insulin secretion and insulin release responses to glucose, glucagon, arginine and meals , 1980, Diabetologia.

[41]  M. Davidson,et al.  The effect of nicotinic acid on growth hormone-induced lipolysis and glucose intolerance. , 1973, The Journal of laboratory and clinical medicine.

[42]  K. Johansen,et al.  Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics , 1970, Diabetologia.

[43]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[44]  B. Houssay.  The Hypophysis and Metabolism , 1936 .

[45]  D. Dunger,et al.  Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[46]  M. Bouxsein,et al.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. , 2004, The Journal of clinical investigation.

[47]  T. Jørgensen,et al.  Heart Disease : A Population-Based Case-Control Study Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic , 2002 .

[48]  K. Højlund,et al.  Development and clinical evaluation of a novel immunoassay for the binary complex of IGF-I and IGF-binding protein-1 in human serum. , 2002, The Journal of clinical endocrinology and metabolism.

[49]  S. Kira,et al.  Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men , 2002, International Journal of Obesity.

[50]  D. Dunger,et al.  Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus. , 1998, Metabolism: clinical and experimental.

[51]  J. Cunningham,et al.  The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. , 1995, The Journal of clinical endocrinology and metabolism.

[52]  R. Baxter,et al.  Binding proteins for the insulin-like growth factors: structure, regulation and function. , 1989, Progress in growth factor research.

[53]  L. Lönn,et al.  Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. , 1997, The Journal of clinical endocrinology and metabolism.